Insmed
INSM
#542
Rank
$43.50 B
Marketcap
$204.00
Share price
-0.51%
Change (1 day)
170.81%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $1.41 Billion USD

According to Insmed's latest financial reports the company's total liabilities are $1.41 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$1.73 B4.7%
2023-12-31$1.66 B5.95%
2022-12-31$1.56 B88.28%
2021-12-31$0.83 B60.12%
2020-12-31$0.52 B8.25%
2019-12-31$0.48 B21.28%
2018-12-31$0.39 B292.41%
2017-12-31$0.10 B20.98%
2016-12-31$83.47 M86.08%
2015-12-31$44.85 M0.52%
2014-12-31$44.62 M34.52%
2013-12-31$33.17 M1.51%
2012-12-31$32.67 M487.12%
2011-12-31$5.56 M62.65%
2010-12-31$3.42 M23.05%
2009-12-31$2.78 M-63.32%
2008-12-31$7.58 M-5.38%
2007-12-31$8.01 M-44.62%
2006-12-31$14.46 M17.24%
2005-12-31$12.34 M113.66%
2004-12-31$5.77 M60.8%
2003-12-31$3.59 M-26.09%
2002-12-31$4.86 M-59.2%
2001-12-31$11.91 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
$2.17 B 53.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$62.53 B 4,319.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
$37.07 B 2,519.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
$1.20 B-14.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
$0.53 B-61.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$7.54 B 433.05%๐Ÿ‡บ๐Ÿ‡ธ USA